FA vs REGN
First Advantage Corp (FA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
First Advantage Corp (FA) is a specialty business services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FA currently screens at market cap $2.72B and trailing P/E 317.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FA and REGN stock pages for the full models.
Not investment advice.